C. Varns
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 9
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 2
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 3
- Oncology top 2%
- CAR-T cell therapy research 3
- Immunology top 5%
-
- Glycosylation and Glycoproteins Research 1
-
- CNS Lymphoma Diagnosis and Treatment 1
-
- Lung Cancer Treatments and Mutations 1
- Co-authors
- A.J. Grillo-LópezChristine A. WhiteB.K. DallaireM. S. CzuczmanRonald LevyDonald KlippensteinJ. RosenbergC. Jonas
- Journals
- Current Pharmaceutical Biotechnology (2 papers)Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesSwitzerland
In The Last Decade
C. Varns
9 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Pathology and Forensic Medicine 1.5k
- Genetics 795
- Radiology, Nuclear Medicine and Imaging 969
- Oncology 986
- Immunology 572
Countries citing papers authored by C. Varns
This map shows the geographic impact of C. Varns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Varns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Varns more than expected).
Fields of papers citing papers by C. Varns
This network shows the impact of papers produced by C. Varns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Varns. The network helps show where C. Varns may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Varns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 17 | |
| 2 | 2000 | 54 | |
| 3 | 2000 | 118 | |
| 4 | 1999 | 308 | |
| 5 | Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. | 1999 | 226 |
| 6 | Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapybreakdown → | 1999 | 672 |
| 7 | IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.breakdown → | 1997 | 527 |
| 8 | 1997 | 193 | |
| 9 | Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. | 1996 | 273 |
About C. Varns
C. Varns is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 9 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers), CAR-T cell therapy research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), CNS Lymphoma Diagnosis and Treatment (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.5k citations), Genetics (795 citations) and Radiology, Nuclear Medicine and Imaging (969 citations). C. Varns has collaborated with scholars based in United States and Switzerland. Frequent co-authors include A.J. Grillo-López, Christine A. White, B.K. Dallaire, M. S. Czuczman, Ronald Levy, Donald Klippenstein, J. Rosenberg, C. Jonas, AF LoBuglio and Mansoor N. Saleh. Their work appears in journals such as Current Pharmaceutical Biotechnology, Journal of Clinical Oncology, Annals of Oncology, Biochemical Society Transactions and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.